BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36528529)

  • 61. [Radical cystectomy in patients with pathological non-muscle invasive bladder cancer].
    Hao H; Su XH; Zheng W; Ge P; He Q; Shen Q; Yang XY; Zhang Z; Li XS; Lin J; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):627-631. PubMed ID: 29263502
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.
    Takayanagi A; Masumori N; Takahashi A; Takagi Y; Tsukamoto T
    Int J Urol; 2012 Mar; 19(3):229-33. PubMed ID: 22121922
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study.
    Kerroumi S; Neuzillet Y; Soorojebally Y; Radulescu C; Talhi R; Taleb S; Herve CJ; Rouanne M; Abdou A; Bosset P; Bazzi A; Yousfi MJ; Lebret T
    Urol Oncol; 2021 Aug; 39(8):497.e1-497.e8. PubMed ID: 33579627
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Systematic review of the oncological and functional outcomes of pelvic organ-preserving radical cystectomy (RC) compared with standard RC in women who undergo curative surgery and orthotopic neobladder substitution for bladder cancer.
    Veskimäe E; Neuzillet Y; Rouanne M; MacLennan S; Lam TBL; Yuan Y; Compérat E; Cowan NC; Gakis G; van der Heijden AG; Ribal MJ; Witjes JA; Lebrét T
    BJU Int; 2017 Jul; 120(1):12-24. PubMed ID: 28220653
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oncological Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of Bladder.
    Bejrananda T; Pripatnanont C; Tanthanuch M; Karnjanawanichkul W
    J Med Assoc Thai; 2017 Jan; 100(1):24-32. PubMed ID: 29911376
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pathological characteristics and prognostic indicators of different histopathological types of urinary bladder cancer following radical cystectomy in a large single-center Egyptian cohort.
    Martin JW; Vernez SL; Lotan Y; Abdelhalim A; Dutta R; Shokeir A; Abol-Enein H; Mosbah A; Ghoneim M; Youssef RF
    World J Urol; 2018 Nov; 36(11):1835-1843. PubMed ID: 29761225
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of Body Mass Index and Pretreatment Hemoglobin Level on Prognosis Following Radical Cystectomy for Bladder Cancer in Males and Females.
    Bi H; Huang Y; Wang G; Ma L; Lu M
    Urol Int; 2020; 104(1-2):28-35. PubMed ID: 31212287
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advanced bladder carcinoma treated by cystectomy: a report on twenty-three years experience (with special reference to salvage cystectomy following radical radiotherapy).
    Weaver PC; Learmonth ID; Lloyd Thomas T; Hutter BF; Cox R; Dixon P
    Clin Oncol; 1979 Mar; 5(1):3-9. PubMed ID: 421385
    [No Abstract]   [Full Text] [Related]  

  • 69. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
    Kim HS; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Age, tumour stage, and preoperative serum albumin level are independent predictors of mortality after radical cystectomy for treatment of bladder cancer in Hong Kong Chinese.
    Chan ES; Yip SK; Hou SM; Cheung HY; Lee WM; Ng CF
    Hong Kong Med J; 2013 Oct; 19(5):400-6. PubMed ID: 23926174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy.
    Sathianathen NJ; Jarosek S; Lawrentschuk N; Bolton D; Konety BR
    Eur Urol Focus; 2019 Jul; 5(4):658-663. PubMed ID: 29366857
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multiple factor analysis of metachronous upper urinary tract transitional cell carcinoma after radical cystectomy.
    Wang P; Luo JD; Wu WF; Wang S; Cai SL; Shen BH; Shi SF; Wei KX; Zhang ZG; Chen ZD
    Braz J Med Biol Res; 2007 Jul; 40(7):979-84. PubMed ID: 17653452
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
    Renninger M; Fahmy O; Schubert T; Schmid MA; Hassan F; Stenzl A; Gakis G
    World J Urol; 2020 Feb; 38(2):397-406. PubMed ID: 31030231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Incidence and prognosis of clinically significant incidental prostate cancer after radical cystectomy for bladder cancer.
    Fernández-Conejo G; de la Peña E; Hernández V; Castro A; Pérez-Fernández E; Llorente C
    Arch Esp Urol; 2019 Nov; 72(9):915-920. PubMed ID: 31697251
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer.
    Porreca A; Palmer K; Artibani W; Antonelli A; Bianchi L; Brunocilla E; Bocciardi AM; Brausi M; Busetto GM; Carini M; Carrieri G; Celia A; Cindolo L; Cochetti G; Colombo R; De Berardinis E; De Cobelli O; Di Maida F; Ercolino A; Gaboardi F; Galfano A; Gallina A; Gallucci M; Introini C; Mearini E; Minervini A; Montorsi F; Musi G; Pini G; Schiavina R; Secco S; Serni S; Simeone C; Tasso G; D'Agostino D
    BMC Cancer; 2021 Jan; 21(1):51. PubMed ID: 33430820
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radical cystectomy for bladder cancer: oncologic outcome in 271 Chinese patients.
    Zhang ZL; Dong P; Li YH; Liu ZW; Yao K; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2014 Mar; 33(3):165-71. PubMed ID: 23958053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prevalence and outcomes of transurethral resection versus radical cystectomy for muscle-infiltrating bladder cancer in the United States: A population-based cohort study.
    Zheng Y; Ye Y; Chen J; Wei Z; Liu Z; Yu K; Zhang X
    Int J Surg; 2022 Jul; 103():106693. PubMed ID: 35690361
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
    Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does radical cystectomy outperform other bladder preservative treatments in elderly patients with advanced bladder cancer?
    Chen CL; Liu CY; Cha TL; Hsu CY; Chou YC; Wu ST; Meng E; Sun GH; Yu DS; Tsao CW
    J Chin Med Assoc; 2015 Aug; 78(8):469-74. PubMed ID: 26074367
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.
    Hara T; Matsuyama H; Kamiryo Y; Hayashida S; Yamamoto N; Nasu T; Joko K; Baba Y; Suga A; Yamamoto M; Aoki A; Takai K; Yoshihiro S; Konishi M; Sakano S; Imoto K; Tei Y; Yamaguchi S; Yano S;
    Int J Clin Oncol; 2016 Feb; 21(1):139-47. PubMed ID: 26077140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.